Related Experiment Video
Updated: Jul 11, 2026

Visualizing Single-Stranded DNA Foci in the G1 Phase of the Cell Cycle
Published on: December 22, 2023
In vivo significance of the G2 restriction point
Floris Foijer1, Elly Delzenne-Goette, Marleen Dekker
1Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Abstract:
Loss of activity of the retinoblastoma pathway is a common event in human cancer. Mouse models have revealed that tumorigenesis by loss of Rb was accelerated by concomitant loss of the cell cycle inhibitor p27KIP1. This has been attributed to reduced apoptosis and weakening of the G1 checkpoint. However, the role of p27KIP1 in a recently identified G2 restriction point may offer an alternative explanation for this synergy. Here, we have investigated the significance of the G2 restriction point in Rb-deficient pituitaries. We show that Rb loss in the pituitary gland activated the G2 restriction point, as evidenced by the appearance of cyclin B1-p27KIP1 complexes. Somewhat unexpectedly, these complexes remained present in Rb-deficient tumors. These results indicate that the G2 restriction point does operate in vivo. However, in the pituitary gland, this mechanism seems to retard rather than to prevent tumor growth.
Insights
Retinoblastoma (Rb) loss in the pituitary activates a G2 restriction point, indicated by cyclin B1-p27KIP1 complexes. These complexes persist in Rb-deficient tumors, suggesting the G2 checkpoint retards, but does not prevent, pituitary tumor growth.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Loss of the retinoblastoma (Rb) pathway is common in human cancers.
- Mouse models show Rb loss accelerates tumorigenesis when p27KIP1 is also lost, potentially due to G1 checkpoint weakening.
- The role of p27KIP1 in the G2 restriction point offers an alternative explanation for this synergy.
Purpose of the Study:
- To investigate the significance of the G2 restriction point in Rb-deficient pituitary glands.
- To determine if the G2 restriction point operates in vivo in the context of Rb loss.
- To understand the role of p27KIP1 in the G2 restriction point during tumorigenesis.
Main Methods:
- Analysis of Rb-deficient pituitary glands.
- Detection of cyclin B1-p27KIP1 complexes as a marker for G2 restriction point activation.
- Examination of Rb-deficient tumors to assess the persistence of these complexes.
Main Results:
- Rb loss in the pituitary gland activates the G2 restriction point.
- Activation is evidenced by the formation of cyclin B1-p27KIP1 complexes.
- These cyclin B1-p27KIP1 complexes were found to be present in Rb-deficient tumors.
Conclusions:
- The G2 restriction point is operational in vivo.
- In the pituitary gland, Rb loss leads to the activation of the G2 restriction point.
- This G2 restriction point mechanism appears to retard, rather than prevent, tumor growth in Rb-deficient pituitaries.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

